Atai Beckley Ownership | Who Owns Atai Beckley?
Atai Beckley Ownership Summary
Atai Beckley is owned by 2.13% institutional investors, 6.67% insiders, and 91.20% retail investors. Ubs group is the largest institutional shareholder, holding 3.91% of ATAI shares. ARK Genomic Revolution ETF is the top mutual fund, with 0.73% of its assets in Atai Beckley shares.
ATAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Atai Beckley | 2.13% | 6.67% | 91.20% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Idea | Psychedelic Stocks List | 31.75% | 11.99% | 56.26% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ubs group | 7.68M | 3.91% | $40.61M |
| Adage capital partners gp | 5.43M | 2.76% | $28.75M |
| Morgan stanley | 4.82M | 2.45% | $25.47M |
| Ally bridge group (ny) | 2.29M | 1.16% | $12.10M |
| Ark investment management | 2.02M | 1.03% | $10.68B |
| T. rowe price investment management | 1.94M | 0.99% | $10.26M |
| Blackrock | 1.31M | 0.82% | $1.74M |
| Millennium management | 981.56K | 0.61% | $1.31M |
| Pale fire capital se | 1.08M | 0.55% | $5.72M |
| Marshall wace, llp | 1.07M | 0.54% | $5.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ally bridge group (ny) | 2.29M | 7.37% | $12.10M |
| Brown university | 718.50K | 2.25% | $3.80M |
| Pale fire capital se | 1.08M | 0.63% | $5.72M |
| Adar1 capital management | 913.24K | 0.45% | $4.83M |
| Advisorshares investments | 506.31K | 0.44% | $2.68M |
| Catalio capital management, lp | 196.86K | 0.19% | $1.04M |
| Centerbook partners lp | 651.13K | 0.17% | $3.44M |
| Numerai gp | 153.80K | 0.11% | $813.60K |
| Bright futures wealth management, llc. | 25.00K | 0.10% | $132.25K |
| Dauntless investment group | 31.16K | 0.10% | $164.83K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ally bridge group (ny) | 2.29M | 7.37% | 2.29M |
| Ark investment management | 2.02M | 0.06% | 2.02M |
| T. rowe price investment management | 1.94M | 0.01% | 1.94M |
| Morgan stanley | 4.82M | 0.00% | 1.32M |
| Adar1 capital management | 913.24K | 0.45% | 913.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Walleye capital | - | - | -2.26M |
| Pale fire capital se | 1.08M | 0.63% | -1.56M |
| Davidson kempner capital management lp | - | - | -1.41M |
| Franklin resources | - | - | -356.36K |
| Citadel advisors | 3.08K | - | -304.74K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ally bridge group (ny) | 2.29M | 7.37% | 2.29M | $12.10M |
| Ark investment management | 2.02M | 0.06% | 2.02M | $10.68B |
| T. rowe price investment management | 1.94M | 0.01% | 1.94M | $10.26M |
| Adar1 capital management | 913.24K | 0.45% | 913.24K | $4.83M |
| Centerbook partners lp | 651.13K | 0.17% | 651.13K | $3.44M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -57.00 |
| Glen eagle advisors | -166.00 |
| Redwood wealth management group | -200.00 |
| Legend financial advisors | -233.00 |
| Venturi wealth management | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 46 | -50.00% | 4,177,343 | -82.19% | 2 | 1.20% | 29 | -25.64% | 2 | -90.91% |
| Jun 30, 2025 | 97 | 14.12% | 29,160,750 | 33.18% | 16 | 10.72% | 41 | 46.43% | 23 | 9.52% |
| Mar 31, 2025 | 85 | -6.59% | 21,905,949 | 50.78% | 12 | 15.19% | 28 | -33.33% | 21 | 61.54% |
| Dec 31, 2024 | 88 | 14.29% | 14,501,746 | 24.52% | 9 | 17.17% | 41 | 78.26% | 13 | -38.10% |
| Sep 30, 2024 | 76 | -15.56% | 11,574,906 | -3.38% | 7 | 12.68% | 22 | -29.03% | 21 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 1.57M | 0.73% | -5.59K |
| Candriam Eqs L Biotech C USD Cap | 1.17M | 0.55% | 1.17M |
| iShares Biotechnology ETF | 771.79K | 0.46% | - |
| Kieger Impact Healthcare A USD Acc | 644.10K | 0.38% | 205.80K |
| Horizons Psychedelic Stock ETF | 520.20K | 0.31% | -82.78K |
| Morgan Stanley Inst Inception I | 511.99K | 0.24% | - |
| Morgan Stanley Inception | 511.99K | 0.24% | - |
| AdvisorShares Psychedelics ETF | 450.35K | 0.21% | - |
| Vanguard Health Care ETF | 432.04K | 0.20% | -4.90K |
| EQ/Morgan Stanley Small Cap Growth K | 316.73K | 0.15% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 14, 2025 | Apeiron Investment Group Ltd. | - | Buy | $19.00M |
| Mar 21, 2025 | Kirpekar Sahil | Chief Business Officer | Sell | $65.56K |
| Mar 21, 2025 | Craig Kevin James | Chief Medical Officer | Sell | $15.61K |
| Mar 21, 2025 | Rao Srinivas | See Remarks | Sell | $101.81K |
| Mar 21, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Sell | $45.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 2 | 5 |
| 2024 Q4 | - | - |
ATAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools